Delivery Order SPE2DB22D2214-SPE2DB24FS2ZS

Award Date 12/20/23
Potential Completion Date 12/21/23
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,415.58, is a Delivery Order for the procurement of HYZAAR 100-25 Tablets with an ultimate completion date of May 23, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,326.65 and is for the delivery of HYZAAR 100-12.5 TABLET 90S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a firm fixed price delivery order between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a potential value of $1,102.08 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The $2,275.00 firm-fixed price delivery order is for the supply of HYZAAR 100-25 Tablets (30 count) to support DLA's medical supply requirements. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the main...
This federal contract award, with the ID SPE2DX15D2013|SPE2DX24F29S6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,955.78 firm fixed-price delivery order is for the provision of HYZAAR 100-25 TABLET 30S, a pharmaceutical product, with a completion date of January 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FC4F1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,270.92 firm fixed-price delivery order covers the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a performance period through June 26, 2024. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of HYZAAR 50-12.5 tablets. The firm-fixed-price delivery order has a ceiling value of $1,904.22 and an ultimate completion date of December 12, 2023. The contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNGTE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,299.69 delivery order contract is for the supply of HYZAAR 50-12.5 TABLET 30S, a medication, and is a Firm Fixed Price contract. The award date is April 30, 2025, with a completion date of May 1, 2025. The contract is not set aside and is an open competition award....
This federal contract award is for the delivery of HYZAAR 100-25 TABLET 30S (NSN 4564885775) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds several other federal contracts with agencies like the Department of Justice. The contract is a Delivery Order with a Firm Fixed Price of $2,934.16 and has an ultimate completion date of June 13, 2024. It...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $18,492.07 award is for the supply of Hyzaar 100-25 tablets, a brand name pharmaceutical product. AmerisourceBergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS2ZS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,676.81, is for the supply of HYZAAR 100-12.5 TABLET 30S medication to support military healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military healthcare system. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/13/25, 9:57 AM